Eli Lilly Ranks Among Top Large-Cap Performers as GLP-1 Drug Sales Exceed Billions
Eli Lilly (NYSE:LLY) has quickly emerged as one of Wall Street’s biggest winners, fueled by explosive demand for its new generation of weight-loss and diabetes treatments. The company’s GLP-1 drugs, including Mounjaro and the…



















